Pointe Capital Management LLC Gilead Sciences, Inc. Transaction History

Pointe Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$77.31 - $88.08 $48,009 - $54,697	621 New	621 $51,000
Q4 2018 Feb 06, 2019	SELL	$60.54 - $79.0 $162,549 - $212,115	-2,685 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$71.28 - $78.92 $27,086 - $29,989	-380 Reduced 12.4%	2,685 $207,000
Q2 2018 Aug 10, 2018	SELL	$64.88 - $75.68 $36,008 - $42,002	-555 Reduced 15.33%	3,065 $217,000
Q4 2017 Jan 12, 2018	SELL	$71.15 - $83.52 $250,092 - $293,572	-3,515 Reduced 49.26%	3,620 $259,000
Q3 2017 Oct 16, 2017	BUY	$72.11 - $85.47 $514,504 - $609,828	7,135	7,135 $578,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Pointe Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Pointe Capital Management LLC with notifications on news.